128 filings
6-K
SPRC
SciSparc Ltd
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
424B5
SPRC
SciSparc Ltd
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
SPRC
SciSparc Ltd
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
SPRC
SciSparc Ltd
3 Dec 19
Current report (foreign)
12:00am
6-K
SPRC
SciSparc Ltd
26 Nov 19
Report of Foreign Private Issuer
4:01pm
6-K
xcvsr
19 Nov 19
Report of Foreign Private Issuer
8:33am
6-K
tvm9go5 sc
13 Nov 19
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
4:07pm
6-K
yuw3jtvegeadl1s
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
b1xcn1rz 37
15 Oct 19
Therapix Biosciences Announces Positive Data From Recent Pre-Clinical Study for New Drug Candidate THX-210
4:10pm
6-K
ubeiv7pgsm9bvrvlj
11 Oct 19
Current Report of Foreign Issuer
12:00am
EFFECT
oq7yw312
6 Sep 19
Notice of effectiveness
12:15am
CORRESP
ux2z76whjx 2xez3sv
3 Sep 19
Correspondence with SEC
12:00am
F-3/A
rt9jw
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
CORRESP
bdl8qz d2
29 Aug 19
Correspondence with SEC
12:00am
6-K
5ylf2s164xj46ti
27 Aug 19
Current report (foreign)
4:13pm
UPLOAD
x6rc3b
26 Aug 19
Letter from SEC
12:00am
F-3
67gvzpgw1sxv9may
22 Aug 19
Shelf registration (foreign)
5:25pm
6-K
lc90gwi
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
atojkrms1xemb12sb
23 Jul 19
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a
4:05pm
6-K
gr0t 4oj1yjxavsm
5 Jul 19
Therapix Biosciences Announces First Quarter 2019 Condensed Financial Data
6:08am